- SLC1A5 REGULATES LIPID METABOLISM AND FORMS AN IMMUNOSUPPRESSIVE TME IN HCCLiao, Jialin; Li, Wenwen; Zhang, Ziyong; Zou, Xuejing; Wu, Dehua; Zhang, DongyanMeeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, MA, 2023-11-10 To 2023-11-14.
- Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk AnalysesZhou, J.*; Chauy, Y. -L. A.; Yooy, J. W.; Lee, S.; Ng, K.; Dee, E. C.; Liu, T.; Wai, A. K. C.; Zhang, Q.; Tse, G.CLINICAL ONCOLOGY, 2022, 34(7): E316-E317.被引 5
- Severe Inflammation in the Background Liver Cirrhosis Correlates with the Development of Poorly Differentiated HCC in HCV-Associated Liver CirrhosisKazuo Tarao; Kaoru Miyakawa; Yohei Miyagi; Shinichi Ohkawa; Soichiro Morinaga; Kenji Oshige; Naoto Yamamoto; Makoto Ueno; Satoshi Kobayashi; Ryou Kameda; Setsuo Tamai; Yoshiyasu Nakamura; Yuichi Endo; Yoichi Kameda; Masahiko OkudairaInternal Medicine, 2012, 51(18): 2495-2501.
期刊论文
The paradox of immunotherapy in NASH-HCC
6被引3阅读
